Avecho Biotechnology Limited (AVE.AX)
AUD 0.0
(-20.0%)
AUD 0.0
(-20.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -43.79 Thousand AUD | -128.05% |
| 2022 | 793.11 Thousand AUD | 200.17% |
| 2021 | -791.78 Thousand AUD | 53.93% |
| 2020 | -1.71 Million AUD | -172.04% |
| 2019 | 2.38 Million AUD | 183.72% |
| 2018 | 840.95 Thousand AUD | -20.41% |
| 2017 | 1.05 Million AUD | -16.08% |
| 2016 | 1.25 Million AUD | -16.45% |
| 2015 | 1.5 Million AUD | 8.73% |
| 2014 | 1.38 Million AUD | 122.12% |
| 2013 | 624 Thousand AUD | 13.25% |
| 2012 | 551 Thousand AUD | -62.67% |
| 2011 | 1.47 Million AUD | -68.02% |
| 2010 | 4.61 Million AUD | 518.77% |
| 2009 | 746 Thousand AUD | -68.83% |
| 2008 | 2.39 Million AUD | 56.71% |
| 2007 | 1.52 Million AUD | 29.63% |
| 2006 | 1.17 Million AUD | 561.8% |
| 2005 | 178 Thousand AUD | 0.0% |
| 2004 | - AUD | -100.0% |
| 2003 | 240.2 Thousand AUD | 72.79% |
| 2002 | 139.01 Thousand AUD | 0.0% |
| 2001 | - AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| 1999 | - AUD | 0.0% |
| 1998 | - AUD | 0.0% |
| 1997 | - AUD | 0.0% |
| 1996 | - AUD | 0.0% |
| 1995 | - AUD | 0.0% |
| 1994 | - AUD | 0.0% |
| 1993 | - AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 207.19 Thousand AUD | 0.0% |
| 2023 Q2 | 213.79 Thousand AUD | 0.0% |
| 2023 FY | -222.49 Thousand AUD | -128.05% |
| 2023 Q4 | -436.28 Thousand AUD | 0.0% |
| 2022 Q4 | 131.92 Thousand AUD | 0.0% |
| 2022 Q2 | 430.84 Thousand AUD | 0.0% |
| 2022 FY | 793.11 Thousand AUD | 200.17% |
| 2021 Q2 | -807.94 Thousand AUD | 0.0% |
| 2021 Q4 | 16.16 Thousand AUD | 0.0% |
| 2021 FY | -791.78 Thousand AUD | 53.93% |
| 2020 Q4 | -1.04 Million AUD | 0.0% |
| 2020 FY | -1.71 Million AUD | -172.04% |
| 2020 Q2 | -675.11 Thousand AUD | 0.0% |
| 2019 Q2 | 3.11 Million AUD | 0.0% |
| 2019 Q4 | -727.09 Thousand AUD | 0.0% |
| 2019 FY | 2.38 Million AUD | 183.72% |
| 2018 FY | 840.95 Thousand AUD | -20.41% |
| 2018 Q2 | 450.57 Thousand AUD | 0.0% |
| 2018 Q4 | 390.37 Thousand AUD | 0.0% |
| 2017 FY | 1.05 Million AUD | -16.08% |
| 2017 Q2 | 763.77 Thousand AUD | 0.0% |
| 2016 FY | 1.25 Million AUD | -16.45% |
| 2016 Q4 | 226.94 Thousand AUD | 0.0% |
| 2016 Q2 | 1.03 Million AUD | 0.0% |
| 2015 FY | 1.5 Million AUD | 8.73% |
| 2015 Q4 | 843.95 Thousand AUD | 0.0% |
| 2015 Q2 | 663 Thousand AUD | 0.0% |
| 2014 Q4 | 1.26 Million AUD | 217.78% |
| 2014 Q1 | 398 Thousand AUD | 0.0% |
| 2014 Q2 | 309 Thousand AUD | -22.36% |
| 2014 FY | 1.38 Million AUD | 122.12% |
| 2014 Q3 | 398 Thousand AUD | 28.8% |
| 2013 Q3 | 213.25 Thousand AUD | 587.9% |
| 2013 Q4 | 398 Thousand AUD | 86.64% |
| 2013 FY | 624 Thousand AUD | 13.25% |
| 2013 Q1 | 213.25 Thousand AUD | 0.0% |
| 2013 Q2 | 31 Thousand AUD | -85.46% |
| 2012 Q2 | 199.25 Thousand AUD | 0.0% |
| 2012 Q1 | 199.25 Thousand AUD | 0.0% |
| 2012 Q4 | 213.25 Thousand AUD | 7.03% |
| 2012 FY | 551 Thousand AUD | -62.67% |
| 2012 Q3 | 199.25 Thousand AUD | 0.0% |
| 2011 Q4 | 199.25 Thousand AUD | -46.0% |
| 2011 Q3 | 369 Thousand AUD | 0.0% |
| 2011 Q2 | 369 Thousand AUD | 0.0% |
| 2011 FY | 1.47 Million AUD | -68.02% |
| 2011 Q1 | 369 Thousand AUD | 0.0% |
| 2010 FY | 4.61 Million AUD | 518.77% |
| 2010 Q3 | 1.15 Million AUD | 0.0% |
| 2010 Q4 | 369 Thousand AUD | -68.02% |
| 2010 Q1 | 1.15 Million AUD | 0.0% |
| 2010 Q2 | 1.15 Million AUD | 0.0% |
| 2009 Q2 | 110.5 Thousand AUD | 0.0% |
| 2009 Q4 | 1.15 Million AUD | 944.34% |
| 2009 Q3 | 110.5 Thousand AUD | 0.0% |
| 2009 FY | 746 Thousand AUD | -68.83% |
| 2009 Q1 | 110.5 Thousand AUD | 0.0% |
| 2008 Q1 | 394.5 Thousand AUD | 0.0% |
| 2008 Q2 | 394.5 Thousand AUD | 0.0% |
| 2008 Q3 | 394.5 Thousand AUD | 0.0% |
| 2008 Q4 | 110.5 Thousand AUD | -71.99% |
| 2008 FY | 2.39 Million AUD | 56.71% |
| 2007 Q2 | 381.75 Thousand AUD | 0.0% |
| 2007 FY | 1.52 Million AUD | 29.63% |
| 2007 Q1 | 381.75 Thousand AUD | 0.0% |
| 2007 Q3 | 381.75 Thousand AUD | 0.0% |
| 2007 Q4 | 394.5 Thousand AUD | 3.34% |
| 2006 FY | 1.17 Million AUD | 561.8% |
| 2006 Q4 | 381.75 Thousand AUD | 29.63% |
| 2006 Q3 | 294.5 Thousand AUD | 0.0% |
| 2006 Q2 | 294.5 Thousand AUD | 0.0% |
| 2006 Q1 | 294.5 Thousand AUD | 0.0% |
| 2005 Q2 | 44.5 Thousand AUD | 0.0% |
| 2005 Q4 | 294.5 Thousand AUD | 561.8% |
| 2005 Q3 | 44.5 Thousand AUD | 0.0% |
| 2005 FY | 178 Thousand AUD | 0.0% |
| 2005 Q1 | 44.5 Thousand AUD | 0.0% |
| 2004 Q4 | 44.5 Thousand AUD | 0.0% |
| 2004 FY | - AUD | -100.0% |
| 2004 Q2 | - AUD | 0.0% |
| 2004 Q3 | - AUD | 0.0% |
| 2004 Q1 | - AUD | 0.0% |
| 2003 Q2 | 60.05 Thousand AUD | 0.0% |
| 2003 Q4 | - AUD | -100.0% |
| 2003 Q3 | 60.05 Thousand AUD | 0.0% |
| 2003 Q1 | 60.05 Thousand AUD | 0.0% |
| 2003 FY | 240.2 Thousand AUD | 72.79% |
| 2002 FY | 139.01 Thousand AUD | 0.0% |
| 2002 Q4 | 60.05 Thousand AUD | 72.79% |
| 2002 Q3 | 34.75 Thousand AUD | 0.0% |
| 2002 Q2 | 34.75 Thousand AUD | 0.0% |
| 2002 Q1 | 34.75 Thousand AUD | 0.0% |
| 2001 Q1 | - AUD | 0.0% |
| 2001 FY | - AUD | 0.0% |
| 2001 Q2 | - AUD | 0.0% |
| 2001 Q4 | 34.75 Thousand AUD | 0.0% |
| 2001 Q3 | - AUD | 0.0% |
| 2000 Q3 | - AUD | 0.0% |
| 2000 Q4 | - AUD | 0.0% |
| 2000 FY | - AUD | 0.0% |
| 2000 Q2 | - AUD | 0.0% |
| 2000 Q1 | - AUD | 0.0% |
| 1999 Q3 | - AUD | 0.0% |
| 1999 FY | - AUD | 0.0% |
| 1999 Q1 | - AUD | 0.0% |
| 1999 Q2 | - AUD | 0.0% |
| 1999 Q4 | - AUD | 0.0% |
| 1998 FY | - AUD | 0.0% |
| 1998 Q4 | - AUD | 0.0% |
| 1998 Q3 | - AUD | 0.0% |
| 1998 Q2 | - AUD | 0.0% |
| 1998 Q1 | - AUD | 0.0% |
| 1997 Q2 | - AUD | 0.0% |
| 1997 Q1 | - AUD | 0.0% |
| 1997 Q3 | - AUD | 0.0% |
| 1997 FY | - AUD | 0.0% |
| 1997 Q4 | - AUD | 0.0% |
| 1996 Q2 | - AUD | 0.0% |
| 1996 Q4 | - AUD | 0.0% |
| 1996 Q1 | - AUD | 0.0% |
| 1996 Q3 | - AUD | 0.0% |
| 1996 FY | - AUD | 0.0% |
| 1995 Q4 | - AUD | 0.0% |
| 1995 FY | - AUD | 0.0% |
| 1995 Q1 | - AUD | 0.0% |
| 1995 Q2 | - AUD | 0.0% |
| 1995 Q3 | - AUD | 0.0% |
| 1994 Q3 | - AUD | 0.0% |
| 1994 FY | - AUD | 0.0% |
| 1994 Q1 | - AUD | 0.0% |
| 1994 Q4 | - AUD | 0.0% |
| 1994 Q2 | - AUD | 0.0% |
| 1993 FY | - AUD | 0.0% |
| 1993 Q2 | - AUD | 0.0% |
| 1993 Q4 | - AUD | 0.0% |
| 1993 Q1 | - AUD | 0.0% |
| 1993 Q3 | - AUD | 0.0% |
| 1992 Q4 | - AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AdAlta Limited | 1.5 Million AUD | 102.904% |
| Acrux Limited | -1.28 Million AUD | 96.589% |
| Actinogen Medical Limited | 9.93 Million AUD | 100.441% |
| AnteoTech Limited | 460.39 Thousand AUD | 109.512% |
| Argenica Therapeutics Limited | 2.59 Million AUD | 101.686% |
| Arovella Therapeutics Limited | -25.97 Thousand AUD | -68.578% |
| Anatara Lifesciences Ltd | -748.91 Thousand AUD | 94.152% |
| Alterity Therapeutics Limited | 3.8 Million AUD | 101.151% |
| Amplia Therapeutics Limited | 4.01 Million AUD | 101.092% |
| Bio-Gene Technology Limited | -301.44 Thousand AUD | 85.472% |
| Biome Australia Limited | 7.66 Million AUD | 100.571% |
| Biotron Limited | -40.49 Thousand AUD | -8.141% |
| Botanix Pharmaceuticals Limited | -6.55 Million AUD | 99.332% |
| BTC Health Limited | 16.36 Thousand AUD | 367.696% |
| Chimeric Therapeutics Limited | 7.45 Million AUD | 100.588% |
| CSL Limited | 15.28 Billion AUD | 100.0% |
| Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 100.381% |
| Clinuvel Pharmaceuticals Limited | 78.09 Million AUD | 100.056% |
| Cynata Therapeutics Limited | 2.31 Million AUD | 101.891% |
| Dimerix Limited | 583.47 Thousand AUD | 107.506% |
| EZZ Life Science Holdings Limited | 50.94 Million AUD | 100.086% |
| Hexima Limited | - AUD | Infinity% |
| Island Pharmaceuticals Limited | 1.25 Million AUD | 103.499% |
| Immuron Limited | 3.33 Million AUD | 101.312% |
| Immutep Limited | 1.44 Million AUD | 103.033% |
| Imugene Limited | -5.83 Million AUD | 99.25% |
| Invex Therapeutics Ltd | 1.21 Million AUD | 103.613% |
| Memphasys Limited | 1606.00 AUD | 2826.961% |
| Nanollose Limited | -348.95 Thousand AUD | 87.45% |
| Neuren Pharmaceuticals Limited | 205.17 Million AUD | 100.021% |
| Noxopharm Limited | -534.81 Thousand AUD | 91.811% |
| NeuroScientific Biopharmaceuticals Limited | -91.33 Thousand AUD | 52.051% |
| Nyrada Inc. | -5164.07 AUD | -748.071% |
| Orthocell Limited | 3.68 Million AUD | 101.187% |
| PharmAust Limited | -1641.00 AUD | -2568.8% |
| Patrys Limited | 1.39 Million AUD | 103.141% |
| Paradigm Biopharmaceuticals Limited | 56.81 Thousand AUD | 177.088% |
| Proteomics International Laboratories Limited | -1.12 Million AUD | 96.101% |
| Prescient Therapeutics Limited | 3.71 Million AUD | 101.18% |
| PYC Therapeutics Limited | 22.05 Million AUD | 100.199% |
| Race Oncology Limited | 1.38 Million AUD | 103.151% |
| Radiopharm Theranostics Limited | -21.3 Million AUD | 99.794% |
| Recce Pharmaceuticals Ltd | -366.76 Thousand AUD | 88.059% |
| Starpharma Holdings Limited | 7.65 Million AUD | 100.572% |
| Telix Pharmaceuticals Limited | 308.5 Million AUD | 100.014% |
| Tissue Repair Ltd | 150.51 Thousand AUD | 129.098% |
| Zelira Therapeutics Limited | 10.28 Thousand AUD | 525.856% |